Syqe is a pharma-tech company developing technologies that enable the precise delivery of a wide range of therapeutic molecules by inhalation.
Syqe Medical is a pocket-sized metered-dose cannabis inhaler designed to allow patients to reach the optimum balance between symptom relief and psycho-activities. The cannabis inhaler transforms psychoactive botanical into mainstream medical drugs. Utilizing selective 100-microgram dosing precision, real-time thermal and flow controllers, lung interfacing and inhalation-based drug delivery platform, enabling patients to recover diseases and regaining their quality of life.
Arc investment: 2018
/PRNewswire/ — Syqe Medical announced today that it has been ranked in Fast Company’s top 10 Biotech companies in the prestigious annual 2020 Most Innovative…